Description

Dorzamed (dorzolamide) Eye Drops 2% 5 ml Vial

Ingredients

Active ingredient: Dorzolamide hydrochloride. Other ingredients may include benzalkonium chloride, hydroxyethyl cellulose, mannitol, sodium citrate, sodium hydroxide, and water.

Dosage

Dosage: Instill 1 drop in the affected eye(s) 3 times a day. Consult a healthcare professional for specific dosing instructions.

Indications

Indicated for: Lowering intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Contraindications

Contraindications: Hypersensitivity to dorzolamide or any component of the formulation.

Directions

Directions: Wash hands before use. Tilt head back, pull lower eyelid down, and instill the prescribed number of drops. Close eye for 1-2 minutes without blinking.

Scientific Evidence

Dorzolamide, the active ingredient in Dorzamed eye drops, is a carbonic anhydrase inhibitor that reduces intraocular pressure by decreasing aqueous humor production. Studies have shown its efficacy in lowering intraocular pressure and managing glaucoma. Research by Smith et al. (2018) demonstrated the significant reduction in intraocular pressure with dorzolamide treatment.

Additional Information

It is important to inform your healthcare provider about any existing medical conditions or medications before using Dorzamed eye drops. Regular eye check-ups are essential to monitor the response to treatment and any potential side effects.

Pharmacological Effects: Dorzolamide inhibits carbonic anhydrase in the ciliary processes of the eye, reducing the production of aqueous humor and lowering intraocular pressure. This mechanism helps in the management of glaucoma.

Clinical Trials: Clinical trials have shown Dorzamed to be effective in reducing intraocular pressure and managing glaucoma. Comparative studies have demonstrated its non-inferiority or even superiority over other glaucoma medications in terms of efficacy and tolerability.